Testing of CpG-Optimized Protein and DNA Vaccines against the Hepatitis B Virus in Chimpanzees for Immunogenicity and Protection from Challenge

Publisher： Karger

E-ISSN： 1423-0100|49|3|144-151

ISSN： 0300-5526

Source： Intervirology, Vol.49, Iss.3, 2006-01, pp. : 144-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA Vaccines for Prophylactic or Therapeutic Immunization against Hepatitis B

By  

Intervirology, Vol. 44, Iss. 2-3, 2001-08 ,pp. : 78-87

Karger

Access to resources Recommend Favorite

DNA Vaccines for Hepatitis C Virus

By  

Intervirology, Vol. 44, Iss. 2-3, 2001-08 ,pp. : 143-153

Karger

Access to resources Recommend Favorite

Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette–Guérin challenge in mice

By  

IMMUNOLOGY, Vol. 19-2805, Iss. 2, 2015-10 ,pp. : 264-270

John Wiley & Sons Inc

Access to resources Recommend Favorite

Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette–Guérin challenge in mice

By  

IMMUNOLOGY, Vol. 146, Iss. 2, 2015-10 ,pp. : 264-270

John Wiley & Sons Inc

Access to resources Recommend Favorite

An improved method for the isolation of hepatitis B virus DNA from human serum

By Changotra Harish   Sehajpal Prabodh  

Indian Journal of Virology, Vol. 24, Iss. 2, 2013-09 ,pp. : 174-179

Springer Publishing Company

Access to resources Recommend Favorite